Skip to content

A feasibility study of a combined mental health and neurodevelopmental assessment for young people in crisis services

Therapeutic Assessment and Neurodivergence Assessment

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN10396938
Enrollment
50
Registered
2026-06-17
Start date
2026-06-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neurodivergence. Mental health, suicidality, self harm Mental and Behavioural Disorders

Interventions

Participants will receive a combined assessment pathway consisting of: 1. Therapeutic Assessment (TA) – a collaborative, brief therapeutic approach designed to help young people and families develop a

Sponsors

University of Glasgow
Lead Sponsor

Eligibility

Sex/Gender
All
Age
12 Years to 18 Years

Inclusion criteria

Inclusion criteria: 1. Children and young people aged 12 years to 17 years 12 months 2. Presentation to crisis services following self-harm and/or suicidal ideation 3. Identified as potentially neurodivergent through clinical judgement and/or previous referral to a Neurodevelopmental Service 4. Participant and family willing and able to provide informed consent/assent as appropriate

Exclusion criteria

Exclusion criteria: 1. Requiring immediate inpatient psychiatric admission 2. Therapeutic Assessment deemed clinically inappropriate, including: 1.1. requirement for an interpreter 1.2. pre-existing intellectual disability 1.3. need for assessment of possible intellectual disability or FASD 1.4. psychosis or significant reality distortion 1.5. intoxication or inebriation 1.6. immediate risk of serious violence or suicide requiring admission 3. Existing established neurodevelopmental diagnosis 4. Lack of capacity to provide informed consent or assent

Design outcomes

Primary

MeasureTime frame
Feasibility and acceptability of the TANDA pathway measured using recruitment rate, retention rate, assessment completion rate, and participant/clinician acceptability questionnaires at enrolment to completion of assessment pathway (approximately 4–8 weeks)

Countries

Scotland, United Kingdom

Contacts

Public ContactJason Lang
jason.lang@glasgow.ac.uk-

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Jul 3, 2026